Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients

Kidney International

Volumn 50, Issue 2, 1996, Pages 543-549

  Birmingham, Daniel J ^a   Shen, Xiao Ping ^a   Hartman, Judith A ^a   Dillon, John J ^a   Hebert, Lee A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS SULFATE; IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE; RECOMBINANT ERYTHROPOIETIN; TETANUS TOXOID;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNIZATION; INTRAVENOUS DRUG ADMINISTRATION; IRON THERAPY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; TETANUS PROPHYLAXIS;

EID: 0029832432     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.347     Document Type: Article

References (19)

1. KIMATA H, YOSHIDA A, ISHIOKA C, MIKAWA H: Erythropoietin enhances immunologlobulin production and proliferation by human plasma cells in a serum-free medium. Clin Immunol Immunopathol 59:495-501, 1991
2. SCHAEFER RM, PACZEK L, HEIDLAND A: Improved immunoglobulin production by B lymphocytes from uraemic patients treated with rHuEPO. Nephrol Dial Transplant 5:742-743, 1990
3. KIMATA H, YOSHIDA A, ISHIOKA C, MIKAWA H: Effect of recombinant human erythropoietin on human IgE production in vitro. Clin Exp Immunol 83:483-487, 1991
4. SENNESAEL JJ, VAN DER NIEPEN P, VERBEELEN DL: Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 40:121-128, 1991
5. PFAFFL W, GROSS H-J, NEUMEIER D, NATTTERMANN U, SAMTLEBEN W, GURLAND HJ: Lymphocyte subsets and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin. Contr Nephrol 66:195-204, 1988
6. GRIMM PC, SINAI-TRIEMAN L, SEKIYA NM, ROBERTSON LS, ROBINSON BJ, FINE RN, ETTENGER RB: Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity. Kidney Int 38:12-18, 1990
7. STOCKENHUBER F, KURZ RW, GEISSLER K, JAHN C, HINTERBERGER W, BALCKE P, LECHNER K: Recombinant human erythropoietin activates a broad spectrum of progenitor cells. Kidney Int 37:150-156, 1990.
8. NEUMAYER HH, KUNZENDORF U, SCHREIBER M: Protective effects of calcium antagonists in human renal transplantation. Kidney Int 41(Suppl 36):S87-S93, 1992
9. SHASHA SM, NUSAM D, LABIN L, KRISTAL B, STEINBERGER O, BARZILAI M, MAKOV EU, SHKOLNIK T: Effect of converting enzyme inhibitor captopril on T cell functions in essential hypertension. Nephron 59:586-590, 1991
10. MANOLAGAS SC, HUSTMYER FG, Yu XP: Immunomodulating properties of 1,25-dihydroxyvitamin D3. Kidney Int 38(Suppl 29):S9-S16, 1990
11. BONA C: Molecular characteristics of anti-polysaccharide antibodies. Springer Semin Immunopathol 15:103-118, 1993
12. JOHNSON DW, FLEMING SJ: The use of vaccines in renal failure. Clin Pharmacokinet 22:434-446, 1992
13. HEBERT LA, BIRMINGHAM DJ, SHEN X-P, COSIO FG: Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes. Clin Immunol Immunopathol 62:301-306, 1992
14. HEBERT LA, BIRMINGHAM DJ, COSIO FG, SHEN X-P, HEBERT MM: Erythropoietin therapy in humans increases expression of erythrocyte complement receptor Type 1 (CD35). J Am Soc Nephrol 4:1786-1791, 1994
15. HEBERT LA, COSIO FG, BIRMINGHAM DJ, MAHAN JD: Biologic significance of the erythrocyte complement receptor: A primate prerequisite. J Lab Clin Med 118:301-308, 1991
16. HEBERT LA: Clearance of immune complexes from the circulation of man and other primates. Am J Kidney Dis 17:352-361, 1991
17. DONATI D, DEGIANNIS D, RASKOVA J, RASKA K JR: Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses. Kidney Int 42:681-689, 1992
18. GIRNDT M, KOHLER H, SCHIEDHELM-WEICK E, MEYER K-H, ZUM BUSCHENFELDE M, FLEISCHER B: T cell activation defect in hemodialysis patients: Evidence for a role of the B7/CD 28 pathway. Kidney Int 44:359-365, 1993
19. KEOWN PA: Recombinant human erythropoietin and renal transplantation. Semin Nephrol 10:52-58, 1990